Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT02701426
Other study ID # 2014_72
Secondary ID 2015-A01085-44
Status Terminated
Phase N/A
First received
Last updated
Start date February 2016
Est. completion date October 29, 2018

Study information

Verified date February 2019
Source University Hospital, Lille
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Background:

Obesity increasingly affects young women and contributes to increased maternal, fetal and neonatal complications. Maternal obesity contributes to the subsequent development of childhood obesity not only through social and environmental mechanisms but also through biological processes referring to the original concept of the developmental health and disease. Data suggest that management during pregnancy through nutrition counseling and adequate physical activity will help to break the familial vicious circle of obesity. To help program to be effective it is important to understand the factors that modulate participation. However, few studies have been conducted to assess the determinants that influence participation.

Goal:

The main objective is to analyze 15 factors that influence participation in a program combining physical activity and nutritional counseling among pregnant women with BMI ≥ 25 kg/m2. Secondary objectives are :

- to identify the data that influence adherence and to show that assiduous women will have a better control of weight gain and a reduction of maternal and fetal complications.

- to understand the biological mechanisms involved

Strategy and method:

A prospective research evaluating the participation in an educational program, including nutritional support and adequate physical activity, will be offered to overweight and obese pregnant women. The program will last 12 weeks, and will include three workshops on diet of the pregnant and lactating women, and the young child. Physical activity sessions will be offered once a week. Fifteen independent variables likely to influence participation will be analyzed. The association between participation and the risk of maternal and fetal pregnancy complications related to obesity will be analysed. Meanwhile, more fundamental research will be considered to determine of the biological factors involved.


Description:

This is a prospective study that will be conducted in pregnant women with a BMI ≥ 25 kg/m2, aged from 18 to 42 years. Participation in the program will be offered between 12 and 22 + 6 weeks of pregnancy. Women with a history of more than 2 miscarriages, severe heart disease (arrhythmia, previous myocardial infarction), bleeding in the first trimester, multiple pregnancy, unstable thyroid disease, hypertension, diabetes, or any other medical conditions that can interfere with the practice of physical activity during pregnancy will not be allowed to participate in the program for medical reasons. The participants will sign an informed consent. The intervention will be an educational program called "Eat well, move well for to the baby's health," including nutritional counselling and physical activity exercises. The control group will receive usual care as a simple information. The intervention will take place between 24 and 36 weeks of pregnancy. Women will be evaluated before (20-24 weeks gestation (SA)), during the intervention (32-34 SA), and finally 8 weeks after childbirth during the postnatal visit. All patients with benefit from obstetric monitoring according with the French recommendations with a monthly consultation and ultrasonography exams at 22 and 32 wks.

Nutritional support will include 3 workshops of 2 hours within the 12 weeks (one workshop per month). Each workshop session will be conducted in groups of 10 to 15 participants. These workshops will aim firstly to inform patients of weight gain recommendations during pregnancy and food recommendations.

Workshop No. 1 will provide information on the goals of weight gain during pregnancy, and will target the implementation of recommendations in terms of diet during pregnancy. The messages will be specifically adapted to the population of obese women including dietary advices, work on erroneous beliefs and representations, work on the motivation to change eating habits and reduction of the harmful link between emotions and eating. Thus, beyond the information, this workshop will have the primary role to develop a diet suitable for pregnancy in obese women. This workshop will be led by a dietician and psychologist. It will take place between the 1st and 4th week of the program.

Workshop No. 2 will inform the benefits of breastfeeding for the child and the mother (including its impact on weight loss during the postpartum period, especially important in obese women). As in the previous workshop, the objective will be to obtain the application of the recommendations on diet during breastfeeding. The general message will be adapted to the problems specific to obese women: work on the social, educational, family, removal of beliefs and motivational brakes. This workshop will be led by a dietician and a midwife and will take place between the 5th and 8th week of the program.

Workshop No. 3 will target the diet in the postpartum period and nutritional needs of the newborn and young child. Beyond dietary information, specific work will be done on motivation to take care of the body after pregnancy and breastfeeding, and especially the fight against the beliefs of the food needs of the newborn, typically found in obese mothers (fear of missing, hunger equated with suffering, the emotional power as substitute) This workshop will take place between the 9th and 12th week of the program and will be led by a dietician and a pediatric nurse.

The exercise program will feature sessions developed by the North Committee of the French Federation of Physical Education and Voluntary Gymnastics. On the program, which lasts 12 weeks per patient, there will be inputs and outputs permanent in the group based on inclusions. The program will be continued for the duration of the research. This program will propose 3 weekly slots of physical activities so that participants can take at least a weekly session. Ideally they will be encouraged to practice a second session and to perform exercises by their own. The personal session can be a walk on the weekend, or an indoor gym classes in one a club, an aqua fit session ... or exercises proposed by the coach to replicate at home. The participants will be able to record and monitor their practice using the logbook.

Evaluation of the program "Eat well, move well for the baby's health" The investigators will do the assessment before during and after the program. Patients will have a logbook in which they will notice physical activity performed. This book will include questionnaires to complete.

1. Food Evaluation The investigators will use a food behavior questionnaire (18 items) and 5 direct questions for a semi-quantitative assessment (sweet beverages consumption, fat, portion sizes). All these elements for assessing eating behavior (uncontrolled eating, hunger, cognitive restriction), the type of food consumed (carbohydrates, fats and proteins). The evaluation will be conducted by dieticians.

2. Evaluation of physical activity Physical activity of patients will be estimated using the French Physical Activity Questionnaire in Pregnancy (QFAPG). This self administered questionnaire will have a qualitative vision (business type) and quantitative activity through 33 questions on "sports" on "household activities " on "activities at work " and also on "activities related to transportation".

Physical activity will be quantitatively measured for each patient who will receive an accelerometer (The Actigraph, Manufacturing Technology Inc., model wActisleep +, Pensacola, Florida USA) that will record the intensity of the efforts made during a period of 7 days.

3. Well-being Evaluation Well-being will be evaluated using the positive and negative affect schedule Questionnaire. which is sensitive to changes over time and assesses the positive and negative affects. It will assess the program's impact on the positive / negative affect.


Recruitment information / eligibility

Status Terminated
Enrollment 195
Est. completion date October 29, 2018
Est. primary completion date October 29, 2018
Accepts healthy volunteers No
Gender Female
Age group 18 Years to 45 Years
Eligibility Inclusion criteria :

- Overweight and obese pregnant women

- Age from 18 to 45 years old

- Singleton pregnancy between 12+0 to 22+6 weeks of pregnancy

Exclusion criteria:

- History of more than 2 miscarriages

- Severe heart disease (arrhythmias, history of myocardial infarction)

- Multiple pregnancy

- Unstable thyroid disease

- Uncontrolled hypertension

- Pre-gestational diabetes

- Bariatric surgery

- Any medical condition that may interfere with physical activity during pregnancy

- Minor or absence of health insurance

- Trusteeship or tutorship

- Refusal to participate in research

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
physical activity and nutritional counseling
The program will last 12 weeks, and will include three workshops on diet of the pregnant and lactating women, and the young child. Physical activity sessions will be offered once a week.

Locations

Country Name City State
France CHRU,Hôpital Jeanne de Flandres Lille

Sponsors (3)

Lead Sponsor Collaborator
University Hospital, Lille Région Nord-Pas de Calais, France, University of Lille Nord de France

Country where clinical trial is conducted

France, 

References & Publications (2)

Deruelle P. [Obesity and pregnancy]. Gynecol Obstet Fertil. 2011 Feb;39(2):100-5. doi: 10.1016/j.gyobfe.2010.12.001. Epub 2011 Feb 12. French. — View Citation

Thangaratinam S, Rogozinska E, Jolly K, Glinkowski S, Roseboom T, Tomlinson JW, Kunz R, Mol BW, Coomarasamy A, Khan KS. Effects of interventions in pregnancy on maternal weight and obstetric outcomes: meta-analysis of randomised evidence. BMJ. 2012 May 16;344:e2088. doi: 10.1136/bmj.e2088. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Number of participant that will participate to the program at 36 weeks of gestation (WG)
Secondary Macrosomia / Birth weight at birth
Secondary Gestational weight gain at birth
Secondary Pregnancy complications Gestational diabetes, gravidic hypertension and preeclampsia between 28 weeks of gestation and term
Secondary Number of patients with C-section or an instrumental extraction C-section vaginal delivery, instrumental extraction at birth
Secondary eating behavior before, during and after the program Three eating factors questionnaire / semi-qualitative questionnaire between 20-24 weeks of gestation, between 32 and 34 weeks of gestation, within 6-8 weeks post-partum
Secondary Questionnaire of physical activity french questionnaire of physical activity between 20-24 weeks of gestation, between 32 and 34 weeks of gestation, within 6-8 weeks post-partum
Secondary Questionnaire for self-esteem Positive and Negative Affect Schedule (PANAS) questionnaire between 20-24 weeks of gestation, between 32 and 34 weeks of gestation, within 6-8 weeks post-partum
Secondary number of neonates with neonatal trauma fractures, shoulder dystocia, brachial plexus injury at birth
Secondary Apgar score at birth
Secondary Arterial umbilical pH at birth
Secondary number of neonates with hyperbilirubinemia total serum bilirubin level > 86 micro mol/L Within 7 days after birth
Secondary Number of neonates needing intensive care transfer Within 7 days after birth
Secondary Neonatal adiposity measurement of shoulder fat thickness in mm at birth
Secondary Maternal weight within 6-8 weeks post-partum
Secondary Infant weight within 6-8 weeks post-partum
Secondary duration of Breastfeeding in weeks within 6-8 weeks post-partum
Secondary Maternal Plasmatic cholesterol levels before, during and after the program between 20-24 weeks of gestation, between 32 and 34 weeks of gestation and at birth
Secondary Maternal Plasmatic leptin levels between 20-24 weeks of gestation, between 32 and 34 weeks of gestation and at birth
Secondary maternal plasmatic glycemic levels between 20-24 weeks of gestation, between 32 and 34 weeks of gestation and at birth
Secondary microRNA levels in maternal milk 2 or 3 days after birth
Secondary Physical activity measured with accelerometers measurements for 1 week between 32 and 34 Weeks of gestation and within 6-8 weeks post-partum
Secondary Maternal Plasmatic triglyceride levels before, during and after the program between 20-24 weeks of gestation, between 32 and 34 weeks of gestation and at birth
Secondary Maternal Plasmatic Apolipoprotein levels before, during and after the program between 20-24 weeks of gestation, between 32 and 34 weeks of gestation and at birth
Secondary Maternal plasmatic apelin levels between 20-24 weeks of gestation, between 32 and 34 weeks of gestation and at birth
Secondary maternal plasmatic insulin levels between 20-24 weeks of gestation, between 32 and 34 weeks of gestation and at birth
Secondary Pittsburgh Sleep Quality Index is a self-report questionnaire that assesses sleep quality over a 1-month time interval. during 7 days between 20-24 weeks of gestation, between 32 and 34 weeks of gestation, within 6-8 weeks post-partum
See also
  Status Clinical Trial Phase
Recruiting NCT04243317 - Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults N/A
Recruiting NCT04101669 - EndoBarrier System Pivotal Trial(Rev E v2) N/A
Terminated NCT03772886 - Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball N/A
Completed NCT03640442 - Modified Ramped Position for Intubation of Obese Females. N/A
Completed NCT04506996 - Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2 N/A
Recruiting NCT06019832 - Analysis of Stem and Non-Stem Tibial Component N/A
Active, not recruiting NCT05891834 - Study of INV-202 in Patients With Obesity and Metabolic Syndrome Phase 2
Active, not recruiting NCT05275959 - Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI) N/A
Recruiting NCT04575194 - Study of the Cardiometabolic Effects of Obesity Pharmacotherapy Phase 4
Completed NCT04513769 - Nutritious Eating With Soul at Rare Variety Cafe N/A
Withdrawn NCT03042897 - Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer N/A
Completed NCT03644524 - Heat Therapy and Cardiometabolic Health in Obese Women N/A
Recruiting NCT05917873 - Metabolic Effects of Four-week Lactate-ketone Ester Supplementation N/A
Active, not recruiting NCT04353258 - Research Intervention to Support Healthy Eating and Exercise N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Recruiting NCT03227575 - Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control N/A
Completed NCT01870947 - Assisted Exercise in Obese Endometrial Cancer Patients N/A
Recruiting NCT05972564 - The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function Phase 1/Phase 2
Recruiting NCT06007404 - Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
Recruiting NCT05371496 - Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction Phase 2